AlphaDetect, the nonprofit organization powered and funded by the Alpha-1 Foundation (A1F), today announced Wave Life ...
AlphaDetect, the nonprofit organization powered and funded by the Alpha-1 Foundation (A1F), today announced Beam Therapeutics ...
Please provide your email address to receive an email when new articles are posted on . Grifols announced that its at-home service to test for genetic risk related to alpha 1-antitrypsin deficiency ...
CORAL GABLES, Fla., Aug. 20, 2025 /PRNewswire/ -- The Alpha-1 Foundation (A1F) is excited to announce the formation of AlphaDetect, a new non-profit subsidiary of A1F, to lead a centralized effort to ...
Now available in the U.S., this free, innovative genetic health risk service lets consumers screen for their risk of alpha 1-antitrypsin deficiency (alpha-1) through a small saliva sample they can ...
Please provide your email address to receive an email when new articles are posted on . Direct-to-consumer testing, combined with clinical follow-up, helped identify patients with undiagnosed alpha-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results